Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2003

01-05-2003

Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors

Authors: Els M.J.J. Berns, Maaike J.M. Dirkzwager-Kiel, Vibeke Kuenen-Boumeester, Mieke Timmermans, Leon C. Verhoog, Ans M.W. van den Ouweland, Hanne Meijer-Heijboer, Jan G.M. Klijn, Theo H. van der Kwast

Published in: Breast Cancer Research and Treatment | Issue 1/2003

Login to get access
Metadata
Title
Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors
Authors
Els M.J.J. Berns
Maaike J.M. Dirkzwager-Kiel
Vibeke Kuenen-Boumeester
Mieke Timmermans
Leon C. Verhoog
Ans M.W. van den Ouweland
Hanne Meijer-Heijboer
Jan G.M. Klijn
Theo H. van der Kwast
Publication date
01-05-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1023347409599

Other articles of this Issue 1/2003

Breast Cancer Research and Treatment 1/2003 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine